The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | A | Alimentary tract and metabolism | |
| 2 | A02 | Drugs for acid related disorders | |
| 3 | A02B | DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) | |
| 4 | A02BC | Proton pump inhibitors | |
| 5 | A02BC01 | Omeprazole |
The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.
| Route | Amount |
|---|---|
| ORAL - Oral | 20 mg |
| PAREN - Parenteral | 20 mg |
| Active Ingredient | Description | |
|---|---|---|
| Omeprazole |
Omeprazole, a racemic mixture of two enantiomers reduces gastric acid secretion through a highly targeted mechanism of action. It is a specific inhibitor of the acid pump in the parietal cell. It is rapidly acting and provides control through reversible inhibition of gastric acid secretion with once daily dosing. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| LOSEC Capsule, Tablet | Health Products Regulatory Authority (IE) | MPI, EU: SmPC | |
| MEDOPRAZOLE Gastro-resistant capsule, hard | Υπουργείο Υγείας (CY) | MPI, EU: SmPC | |
| OMEPRAZOLE Gastro-resistant capsules | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| OMEPRAZOLE Powder for solution for infusion | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| OMEZ Capsule | Health Products Regulatory Authority (ZA) | MPI, Generic | |
| PEDIPPI Powder for oral suspension | Health Products Regulatory Authority (IE) | MPI, EU: SmPC | |
| PRILOSEC Granule for delayed-release oral suspension | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| ULCESEP Hard gelatin capsule | Medicines Authority (MT) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
